2026-01-12 - Analysis Report
## Comprehensive Report on Albemarle Corp (ALB)

### Company Overview
Albemarle Corp is a global leader in lithium and other specialty chemicals.

### Comparative Analysis
- **Return Rate (rate):** 43.91%
- **Return Rate of S&P 500 (VOO) (rate_vs):** 94.03%
- **Divergence (simply the difference in cumulative return on the last day of the data):** -50.10

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|-------|
| 2016-2018  | -10.0% | 35.3% | -13.0% | 1.2 | 9.1B |
| 2017-2019  | -37.0% | 35.3% | -54.0% | 1.2 | 8.6B |
| 2018-2020  | 50.0% | 29.5% | 29.0% | 1.2 | 17.4B |
| 2019-2021  | 140.0% | 29.5% | 96.0% | 1.3 | 27.5B |
| 2020-2022  | 134.0% | 28.5% | 136.0% | 1.3 | 25.5B |
| 2021-2023  | -26.0% | 53.3% | -27.0% | 1.5 | 17.0B |
| 2022-2024  | -139.0% | 68.7% | -158.0% | 1.5 | 10.1B |
| 2023-2025  | -165.0% | 74.5% | -227.0% | 1.8 | 16.6B |

### Recent Stock Price Fluctuations
- **Close:** $161.29
- **Last-market (price increase/decrease):** â†‘ 10.37 (increase)
- **5-day SMA:** $157.09
- **20-day SMA:** $144.99
- **60-day SMA:** $121.34
**Recent Market Trend:** Sharp rebound in price over the past 5 days.

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence
- **Market Risk Indicator (MRI):** 0.70
- **RSI:** 72.88
- **PPO:** 0.36
- **Recent (20 days) relative divergence change:** +4.40 (improving)
- **7-day Rank change:** -2 (-): rank down
- **7-day Dynamic Expected Return change:** -8.90 (-): worsening
- **Expected Return (%):** 7.60%

### Recent News & Significant Events
Multiple recent news headlines suggest positive sentiment towards Albemarle Corp, including: 
* "ALB Stock Surges: Is It Time to Buy?" and "Albemarle's Earnings and Revenues Surpass Estimates in Q3" and other recent market news.

### Analyst Opinions
* Analyst Consensus:
 + Key: Buy
 + Mean (1=StrongBuy~5=Sell): 2.35 (~Buy)
 + Opinions: 23
 + Target Price (avg/high/low): 137.45 / 210.00 / 80.00

### Recent Earnings Analysis
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-11-05 | -1.72 | 1.31 B$ |
| 2025-08-04 | -0.16 | 1.33 B$ |
| 2025-04-30 | 0 | 1.08 B$ |
| 2024-11-06 | -9.45 | 1.35 B$ |
| 2025-11-05 | -9.45 | 1.35 B$ |

### Financial Information

#### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.31B | 8.99% |
| 2025-06-30 | $1.33B | 14.80% |
| 2025-03-31 | $1.08B | 14.51% |
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |

#### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.00B | -1.61% |
| 2025-06-30 | $10.24B | 0.22% |
| 2025-03-31 | $10.03B | 0.41% |
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |

### Comprehensive Analysis
Based on our analysis, Albemarle Corp's stock price has experienced significant fluctuations in recent years. The company's performance has been impacted by market trends, particularly in the lithium market. Recent news headlines suggest positive sentiment towards the company, including its earnings and revenue surpassing estimates. However, our analysis indicates a relatively high level of risk, with some indicators suggesting potential for increased volatility. We recommend investors to carefully consider their investment decisions, taking into account the company's historical performance, recent market trends, and overall market conditions.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.